The rot of having annual CR’s set in under the founders who were both more interested in research than commercialising the product. These were the WASTED YEARS and they expected shareholders to keep ponying up funds for this research year after year right up to when they were finally pushed out.It was REALLY only after Hackett invested and joined the Board that commercialisation became the focus (beginning in 2015) and this refocussing is at last achieving results under the present management.
The rot of having annual CR’s set in under the founders who were...
Add RFX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $24.89M | |||
| Open | High | Low | Value | Volume |
| 11.0¢ | 11.0¢ | 10.5¢ | $88.50K | 816.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 158202 | 10.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.0¢ | 188919 | 3 |
View Market Depth
| Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
10.5¢ |
Change
0.000 ( 4.55 %) |
||||
| Open | High | Low | Volume | ||
| 11.0¢ | 11.0¢ | 10.5¢ | 70145 | ||
| Last updated 15.38pm 03/05/2024 ? | |||||
| RFX (ASX) Chart |